Description
BALVERSA 4MG & 5MG TABLETS
First action · last action
2023-08-23 · 2024-09-05
Transactions
3
First transaction's obligation
$87,362
Base + all options value (sum of deltas)
$55,401
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0217
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-08-23+$87,362= $87,362
- Mod P000012023-10-05-$4,262= $83,101
- Mod P000022024-09-05-$27,700= $55,401
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-08-23 | +$87,362 | $87,362 | BALVERSA 4MG & 5MG TABLETS |
| Mod P00001· FUNDING ONLY ACTION | 2023-10-05 | −$4,262 | $83,101 | BALVERSA 4MG & 5MG TABLETS |
| Mod P00002· FUNDING ONLY ACTION | 2024-09-05 | −$27,700 | $55,401 | BALVERSA 4MG & 5MG TABLETS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NVYMGFA53MN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0310 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $384,719 | FY2026 |
| 36C24526N0789 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $20,500 | FY2026 |
| 36C25926F0264 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $384,719 | FY2026 |
| 36C24526N0608 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $20,500 | FY2026 |
| 36C24526N0428 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $20,295 | FY2026 |
| 36C25926F0068 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26223F0677_3600_36F79719D0217_3600 · retrieved 2026-09-26.